百诚医药
(301096)
| 流通市值：36.28亿 | | | 总市值：47.68亿 |
| 流通股本：8311.46万 | | | 总股本：1.09亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 334,895,850.36 | 396,512,404.88 | 292,595,610.38 | 372,740,297.75 |
| 交易性金融资产 | 60,000,000 | 60,000,000 | 80,000,000 | 170,000,000 |
| 应收票据及应收账款 | 525,262,993.75 | 519,462,134.64 | 467,209,142.3 | 471,756,779.5 |
| 应收账款 | 525,262,993.75 | 519,462,134.64 | 467,209,142.3 | 471,756,779.5 |
| 应收款项融资 | 1,267,667.39 | 1,057,964.37 | 7,815,913.12 | 8,505,346.63 |
| 预付款项 | 42,914,176.91 | 35,670,983.83 | 25,171,719.95 | 54,627,741.34 |
| 其他应收款合计 | 10,463,141.89 | 2,813,396.07 | 9,763,234.07 | 2,667,051.57 |
| 存货 | 195,233,260.2 | 180,109,836.75 | 176,442,746.47 | 221,736,301.99 |
| 合同资产 | 437,245,620.91 | 435,233,548.05 | 426,977,051.19 | 438,406,783.55 |
| 其他流动资产 | 55,988,744.3 | 67,553,732.65 | 66,107,962.16 | 77,829,027.95 |
| 流动资产合计 | 1,663,271,455.71 | 1,698,414,001.24 | 1,552,083,379.64 | 1,818,269,330.28 |
| 非流动资产: | | | | |
| 长期应收款 | 26,055,077.89 | 20,595,665.91 | 20,424,923.61 | - |
| 长期股权投资 | 16,397,906 | 16,398,075.34 | 16,398,075.34 | 36,551,746.66 |
| 其他非流动金融资产 | 190,136,196.51 | 185,948,119.59 | 186,098,119.59 | 167,862,497.01 |
| 投资性房地产 | 3,400,000 | 3,400,000 | 3,400,000 | - |
| 固定资产 | 1,640,318,593.82 | 1,667,532,941.72 | 1,707,597,897.18 | 1,545,330,372.03 |
| 在建工程 | 70,517,938.47 | 72,068,097.83 | 66,668,570.74 | 222,979,028.7 |
| 使用权资产 | 1,547,219.5 | 2,460,237.92 | 2,621,046.26 | 2,790,695.22 |
| 无形资产 | 88,325,915.47 | 89,133,872.69 | 89,796,059.4 | 90,686,866.92 |
| 长期待摊费用 | 1,719,547.41 | 930,800.63 | 1,084,141.57 | 1,153,332.14 |
| 递延所得税资产 | 37,735,909.52 | 37,431,690.79 | 36,866,705.02 | 34,304,846.27 |
| 其他非流动资产 | 11,081,797.85 | 8,068,403.63 | 3,228,700.83 | 26,998,726.91 |
| 非流动资产合计 | 2,087,236,102.44 | 2,103,967,906.05 | 2,134,184,239.54 | 2,128,658,111.86 |
| 资产总计 | 3,750,507,558.15 | 3,802,381,907.29 | 3,686,267,619.18 | 3,946,927,442.14 |
| 流动负债: | | | | |
| 短期借款 | 493,091,888.72 | 518,129,648.61 | 510,612,148.66 | 728,463,642.16 |
| 应付票据及应付账款 | 103,410,055.26 | 105,320,101.5 | 130,142,698.85 | 110,361,562.91 |
| 其中：应付票据 | 6,893,878.51 | 9,483,548.32 | 11,646,497.96 | 15,581,684 |
| 应付账款 | 96,516,176.75 | 95,836,553.18 | 118,496,200.89 | 94,779,878.91 |
| 合同负债 | 83,152,703.64 | 81,937,825.05 | 76,055,784.45 | 95,539,119.98 |
| 应付职工薪酬 | 17,693,100.42 | 16,157,022.73 | 20,449,714.55 | 18,013,275.64 |
| 应交税费 | 5,715,605.93 | 2,664,125.11 | 7,063,013.33 | 7,303,035.62 |
| 其他应付款合计 | 2,541,461.81 | 2,687,085.43 | 5,224,779.24 | 3,876,408.58 |
| 一年内到期的非流动负债 | 196,066,338.03 | 179,561,599.4 | 170,363,969.2 | 66,443,596.2 |
| 流动负债合计 | 901,671,153.81 | 906,457,407.83 | 919,912,108.28 | 1,030,000,641.09 |
| 非流动负债: | | | | |
| 长期借款 | 284,726,687.8 | 310,007,497.24 | 189,507,027.78 | 238,670,937.99 |
| 租赁负债 | 348,618.21 | 2,501,584.11 | 2,337,213.44 | 2,864,288.3 |
| 预计负债 | 50,139,920.24 | 59,858,558.6 | 61,836,919.65 | 64,258,513.89 |
| 递延收益 | 19,864,789.63 | 21,779,487.27 | 23,720,580.21 | 25,661,673.15 |
| 非流动负债合计 | 355,080,015.88 | 394,147,127.22 | 277,401,741.08 | 331,455,413.33 |
| 负债合计 | 1,256,751,169.69 | 1,300,604,535.05 | 1,197,313,849.36 | 1,361,456,054.42 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 109,228,284 | 109,228,284 | 109,228,284 | 109,228,284 |
| 资本公积 | 2,108,573,012.15 | 2,106,813,173.52 | 2,106,813,173.52 | 2,106,813,173.52 |
| 减:库存股 | 49,998,224.77 | 49,998,224.77 | 49,998,224.77 | 49,998,224.77 |
| 其他综合收益 | -174,586.89 | -172,409.97 | -183,553.97 | -185,676.11 |
| 盈余公积 | 54,614,142 | 54,614,142 | 54,614,142 | 54,614,142 |
| 未分配利润 | 270,077,958.11 | 281,292,407.46 | 268,479,949.04 | 364,999,689.08 |
| 归属于母公司股东权益合计 | 2,492,320,584.6 | 2,501,777,372.24 | 2,488,953,769.82 | 2,585,471,387.72 |
| 少数股东权益 | 1,435,803.86 | - | - | - |
| 股东权益合计 | 2,493,756,388.46 | 2,501,777,372.24 | 2,488,953,769.82 | 2,585,471,387.72 |
| 负债和股东权益合计 | 3,750,507,558.15 | 3,802,381,907.29 | 3,686,267,619.18 | 3,946,927,442.14 |
| 公告日期 | 2026-08-27 | 2026-04-24 | 2026-04-24 | 2025-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |